MedPath

Infant Fecal Insult Study

Not Applicable
Completed
Conditions
Dermatitis
Registration Number
NCT02979210
Lead Sponsor
Kimberly-Clark Corporation
Brief Summary

The rationale for the study is to better understand the dynamics of skin microflora following skin barrier disruption in an adult dermatitis model. The results from this study will provide insights in the complex interaction between skin microbiome and epidermis under normal and disease conditions

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • Healthy Subjects with Fitzpatrick Skin Types I, II or III
Exclusion Criteria
  • Subjects with visible skin disease, tattoos, skin condition, or abnormal skin color

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Type of microbes present on skin after exposure to artificial fecal insultup to 7 days

Microbes will be identified by metagenomic sequencing

Relative abundance of microbes present on skin measured in picograms of DNAup to 7 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Reliance Clinical Testing Service

🇺🇸

Irving, Texas, United States

Reliance Clinical Testing Service
🇺🇸Irving, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.